Welcome to Peptide Card of AntiTbPdb
This page displays user query in tabular form. |
R-(zDhb)-PVLALVAAVAATSAAY details |
Primary information | |
---|---|
ID | antitb_1506, |
Name | 25681127 |
N-Terminal modification | SP508A |
C-Terminal Modification | R-(zDhb)-PVLALVAAVAATSAAY |
Chemical Modification | R =3-hydroxyldodecanoyl |
Linear/Cyclic | Free |
Length | Dhb= Dihydrobutyric acid |
Chirality | Linear |
Nature | 18 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Derived from Pseudomonas syringae |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis ATCC14468 |
Cell Line | MIC = 31.25 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Specific interaction with membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1507, |
Name | 25681127 |
N-Terminal modification | SP508B |
C-Terminal Modification | R-(zDhb)-PVLALVAAVAATSAAY |
Chemical Modification | R =3-hydroxyldodecanoyl |
Linear/Cyclic | Free |
Length | Dhb= Dihydrobutyric acid, o-C=o linkage between 12 and 16 amino acid residue |
Chirality | Cyclic |
Nature | 18 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Pseudomonas syringae |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis ATCC14468 |
Cell Line | MIC = 62.5 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | |
Combination Therapy | Specific interaction with membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1510, |
Name | 25681127 |
N-Terminal modification | SP508A |
C-Terminal Modification | R-(zDhb)-PVLALVAAVAATSAAY |
Chemical Modification | R =3-hydroxyldodecanoyl |
Linear/Cyclic | Free |
Length | Dhb= Dihydrobutyric acid |
Chirality | Linear |
Nature | 18 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Derived from Pseudomonas syringae |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis ATCC14468 |
Cell Line | Reduction in zone to15 mm at 31.25 mg/L |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Specific interaction with membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1511, |
Name | 25681127 |
N-Terminal modification | SP508B |
C-Terminal Modification | R-(zDhb)-PVLALVAAVAATSAAY |
Chemical Modification | R =3-hydroxyldodecanoyl |
Linear/Cyclic | Free |
Length | Dhb= Dihydrobutyric acid, o-C=o linkage between 12 and 16 amino acid residue |
Chirality | Cyclic |
Nature | 18 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Pseudomonas syringae |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis ATCC14468 |
Cell Line | Reduction in zone to 18 mm at 62.5 mg/L |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | |
Combination Therapy | Specific interaction with membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas |
Tertiary Structure (Technique) | Not Predicted), |